Sugi Predict

Sugi Predict / Compounds / SCHEMBL1373022

SCHEMBL1373022

SCHEMBL1373022

CCOC(=O)n1nc2c(c1NC(=O)c1ccccc1NC(=O)c1cccn1C)CN(S(=O)(=O)c1cc(F)cc(F)c1)C2(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 1/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ KMT2A Q03164 5/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 3/20 0.34
▸ LMNA P02545 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ MRGPRX1 Q96LB2 3/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ TSPO P30536 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1371564 0.88 SMN1; SMN2 (0.37) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1374731 0.87 IGF1R (0.41) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1373008 0.85 SMN1; SMN2 (0.34) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1372191 0.84 HSD17B10 (0.35) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1373849 0.82 ALDH1A1 (0.40) SMN1; SMN2NPSR1KMT2AKDM4EMAPT
SCHEMBL1372652 0.81 USP2 (0.34) IGF1RSMN1; SMN2HSD17B10KMT2AKDM4E
SCHEMBL1370499 0.80 GRM5 (0.33) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1371665 0.79 IGF1R (0.56) IGF1R
SCHEMBL1370502 0.79 MAPT (0.34) IGF1RSMN1; SMN2HSD17B10NPSR1MAPK1
SCHEMBL1373173 0.78 IGF1R (0.41) IGF1RSMN1; SMN2HSD17B10KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461193-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-06-11 — — US disclosed
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.I. (IT) 2011-11-24 — — US disclosed
US-7968583-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-06-28 — — US disclosed
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 IGF1R 737/4885SMN1; SMN2 3697/4885HSD17B10 3405/4885
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 IGF1R 737/4885SMN1; SMN2 3697/4885HSD17B10 3405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.